Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Scheinberg

Showing results (71-80 of 426) with videos related to

Pageof 43
Sort By:
Immunology|November 1, 1974
Casein-induced experimental amyloidosis. III. Response to mitogens, allogeneic cells, and graft-versus-host reactions in the murine modelM A Scheinberg, E S Cathcart
Biochemical and Biophysical Research Communications|March 17, 1995
Substance P and bradykinin are natural inhibitors of CD13/aminopeptidase NY Xu, D Wellner, D A Scheinberg
Annals of the Rheumatic Diseases|November 14, 2008
Successful treatment with bosentan of non-digital skin ulcers in severe sclerodermaM E G Ferreira, M A Scheinberg
Annals of the Rheumatic Diseases|June 17, 2008
Successful use of rituximab in a patient with recalcitrant livedoid vasculopathyP Zeni, E Finger, M A Scheinberg
Experimental Hematology|June 1, 1997
Cryptic and regulatory epitopes in CD13/aminopeptidase NY Xu, D Wellner, D A Scheinberg
AMB : Revista Da Associacao Medica Brasileira|June 1, 1979
[Introduction of a new method for the detection of antibodies against nuclear antigens. Comparison with radioimmunoassay and indirect immunofluorescence in the rat liver]M A Scheinberg, L Santos, R Diniz
Oncotarget|June 27, 2013
Reaching un-drugable intracellular targets with the long arm of antibodiesDavid A Scheinberg, Tao Dao, Cheng Liu
Oncoimmunology|September 28, 2013
Approaching untargetable tumor-associated antigens with antibodiesTao Dao, Cheng Liu, David A Scheinberg
Bone Marrow Transplantation|October 26, 2005
Radioimmunoconjugates in acute leukemia treatment: the future is radiantJ Kotzerke, D Bunjes, D A Scheinberg
Revista Paulista De Medicina|July 1, 1983
[HLA-Dr in cases of rheumatoid arthritis. Introduction of a new marker of clinical aggressivity]M A Scheinberg, B J de Sampaio
Pageof 43

Showing results (71-80 of 426) with videos related to

Sort By:
Pageof 43
Immunology|November 1, 1974
Casein-induced experimental amyloidosis. III. Response to mitogens, allogeneic cells, and graft-versus-host reactions in the murine modelM A Scheinberg, E S Cathcart
Biochemical and Biophysical Research Communications|March 17, 1995
Substance P and bradykinin are natural inhibitors of CD13/aminopeptidase NY Xu, D Wellner, D A Scheinberg
Annals of the Rheumatic Diseases|November 14, 2008
Successful treatment with bosentan of non-digital skin ulcers in severe sclerodermaM E G Ferreira, M A Scheinberg
Annals of the Rheumatic Diseases|June 17, 2008
Successful use of rituximab in a patient with recalcitrant livedoid vasculopathyP Zeni, E Finger, M A Scheinberg
Experimental Hematology|June 1, 1997
Cryptic and regulatory epitopes in CD13/aminopeptidase NY Xu, D Wellner, D A Scheinberg
AMB : Revista Da Associacao Medica Brasileira|June 1, 1979
[Introduction of a new method for the detection of antibodies against nuclear antigens. Comparison with radioimmunoassay and indirect immunofluorescence in the rat liver]M A Scheinberg, L Santos, R Diniz
Oncotarget|June 27, 2013
Reaching un-drugable intracellular targets with the long arm of antibodiesDavid A Scheinberg, Tao Dao, Cheng Liu
Oncoimmunology|September 28, 2013
Approaching untargetable tumor-associated antigens with antibodiesTao Dao, Cheng Liu, David A Scheinberg
Bone Marrow Transplantation|October 26, 2005
Radioimmunoconjugates in acute leukemia treatment: the future is radiantJ Kotzerke, D Bunjes, D A Scheinberg
Revista Paulista De Medicina|July 1, 1983
[HLA-Dr in cases of rheumatoid arthritis. Introduction of a new marker of clinical aggressivity]M A Scheinberg, B J de Sampaio
Pageof 43